Cavanagh Bethany J — SEC Form 4 filings
SEC reporting owner CIK 2033155. 13 Form 4 filings on record with FilingPulse; latest filed 2026-04-06.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-09-03 to 2026-04-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 8 filings — 23,649 shares, $709,189 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 6,287 shares @ $35.00 ($220,045) in Beam Therapeutics Inc., filed 2025-02-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | SVP, Finance and Treasurer | 13 | — | 8 legs · 23,649 sh · $709,189 | 6 |
Form 4 filings — Cavanagh Bethany J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-06 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 3,242 @ $24.58 | EDGAR |
| 2026-04-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2026-02-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 6,198 @ $35.00 | EDGAR |
| 2026-01-21 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 3,034 @ $30.12 | EDGAR |
| 2025-10-03 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 467 @ $24.53 | EDGAR |
| 2025-04-03 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 3,015 @ $18.35 | EDGAR |
| 2025-04-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2025-02-20 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 6,287 @ $35 | EDGAR |
| 2025-02-03 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 1,117 @ $24.68 | EDGAR |
| 2024-10-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 2,500 @ $0 · Sale (S): 289 @ $23.48 | EDGAR |
| 2024-09-03 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2033155 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →